We are live on ! Find out more
EIP

Epoch Investment Partners Portfolio holdings

AUM $16.5B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+24.3%
3 Year Est. Return
+77.95%
5 Year Est. Return
+103.29%
10 Year Est. Return
+404.8%
AUM
$22.5B
AUM Growth
+$531M
Cap. Flow
-$1.53B
Cap. Flow %
-6.78%
Top 10 Hldgs %
16.04%
Holding
434
New
23
Increased
133
Reduced
230
Closed
26

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$305M
2
MSFT icon
Microsoft
MSFT
+$269M
3
NVDA icon
NVIDIA
NVDA
+$191M
4
LLY icon
Eli Lilly
LLY
+$184M
5
AMZN icon
Amazon
AMZN
+$139M

Sector Composition

Rank Sector Weight
1 Technology 22.37%
2 Healthcare 17.03%
3 Financials 13.96%
4 Industrials 11.52%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
26
HCA Healthcare
HCA
$89.3B
$181M 0.81%
542,906
+85,505
+19% +$26.1M
HD icon
27
Home Depot
HD
$348B
$181M 0.8%
471,566
+11,442
+2% +$4.18M
IBM icon
28
IBM
IBM
$222B
$178M 0.79%
933,543
-200,211
-18% -$36.5M
ABBV icon
29
AbbVie
ABBV
$434B
$177M 0.79%
974,702
-145,431
-13% -$25.1M
COST icon
30
Costco
COST
$421B
$177M 0.79%
241,645
+10,159
+4% +$7.25M
CVX icon
31
Chevron
CVX
$382B
$175M 0.78%
1,111,478
-334,710
-23% -$50.5M
EXP icon
32
Eagle Materials
EXP
$6.44B
$175M 0.78%
643,208
-19,420
-3% -$4.59M
QCOM icon
33
Qualcomm
QCOM
$172B
$174M 0.77%
1,027,398
+174,700
+20% +$27M
BAC icon
34
Bank of America
BAC
$446B
$173M 0.77%
4,571,409
-750,733
-14% -$25.8M
MNST icon
35
Monster Beverage
MNST
$89.3B
$172M 0.76%
2,898,894
+784,606
+37% +$45.1M
CVS icon
36
CVS Health
CVS
$122B
$172M 0.76%
2,150,505
+174,015
+9% +$13.3M
UNP icon
37
Union Pacific
UNP
$174B
$170M 0.75%
690,257
+58,704
+9% +$14.4M
CRM icon
38
Salesforce
CRM
$161B
$167M 0.74%
553,999
-37,306
-6% -$10.8M
MEDP icon
39
Medpace
MEDP
$16.7B
$164M 0.73%
406,446
+53,983
+15% +$19M
PCAR icon
40
PACCAR
PCAR
$68.9B
$163M 0.73%
1,318,525
+259,555
+25% +$27.9M
CPRT icon
41
Copart
CPRT
$27.4B
$162M 0.72%
2,791,737
+1,018,182
+57% +$52.4M
MA icon
42
Mastercard
MA
$491B
$161M 0.72%
334,232
-169,040
-34% -$77.3M
MRK icon
43
Merck
MRK
$322B
$161M 0.71%
1,216,883
+602
+0% +$74.2K
LRCX icon
44
Lam Research
LRCX
$384B
$160M 0.71%
1,651,340
+208,550
+14% +$18.3M
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.14T
$152M 0.68%
362,527
+12,376
+4% +$4.87M
DPZ icon
46
Domino's
DPZ
$11.4B
$152M 0.68%
305,891
+71,199
+30% +$30.9M
FAST icon
47
Fastenal
FAST
$59.6B
$150M 0.67%
3,885,494
+503,892
+15% +$17.8M
LIN icon
48
Linde
LIN
$225B
$148M 0.66%
318,776
-70,331
-18% -$30.5M
WMT icon
49
Walmart Inc
WMT
$891B
$148M 0.66%
2,458,279
+550,819
+29% +$31.5M
ULTA icon
50
Ulta Beauty
ULTA
$23.5B
$147M 0.66%
281,809
+55,688
+25% +$28.8M

Similar funds

Epoch Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Epoch Investment Partners held 434 positions worth $22.5B, up 2.4% from $22B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Epoch Investment Partners withdrew a net $1.53B in Q1 2024, closing 26 positions and reducing 230 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $69.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Epoch Investment Partners opened a new position in Regeneron Pharmaceuticals worth $99.7M.

  • Epoch Investment Partners's largest Q1 2024 buy was Regeneron Pharmaceuticals: 103,551 shares worth $99.7M.
  • Epoch Investment Partners added most to Zoetis in Q1 2024, an estimated $60.9M increase.
  • Epoch Investment Partners's biggest Q1 2024 reduction was Apple, cutting an estimated $305M.
  • Epoch Investment Partners fully exited Berry Global Group, Inc. in Q1 2024, selling an estimated $69.7M.
  • Epoch Investment Partners's ten largest holdings make up 16% of its $22.5B portfolio in Q1 2024.
  • Epoch Investment Partners opened 23 new positions and closed 26 in Q1 2024.
  • Epoch Investment Partners's portfolio value rose 2.4% quarter-over-quarter to $22.5B.

Based on Epoch Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.